# D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

> **NCT04168138** · NA · UNKNOWN · sponsor: **Huihan Wang** · enrollment: 20 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** rhTPO

## Key facts

- **NCT ID:** NCT04168138
- **Lead sponsor:** Huihan Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04168138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04168138, "D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04168138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*